🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

During Colorectal Cancer Awareness Month, we're raising awareness for colon cancer and sharing the importance of knowing your risk, common symptoms and when to see your doctor. Read more from Chris Cann, MD on Yahoo: yhoo.it/4bPGJen

Recent years have seen a concerning rise in cancer diagnoses among young adults across all cancer types. This surge in diagnoses highlights the urgent need for specialized care and resources tailored to the needs of cancer patients aged 18-39. Learn more: foxchase.org/discovery

This week is National Adolescent and Young Adult Cancer Awareness Week and Fox Chase Cancer Center is proud to be the first in Philadelphia to offer a young adult program for patients aged 18-39. Learn more: bit.ly/454OI2e #AYACancerAwarenessWeek

Recently, Fox Chase Cancer Center hosted the PanCAN PurpleStride Philadelphia 2025 Leadership Breakfast with the area’s champions in pancreatic cancer research, all working together for a common goal: to rewrite the future of pancreatic cancer. Sanjay S. Reddy Chris Cann, MD

Cancer rates among younger people have been rising in recent years, and as more young people navigate cancer, there’s the growing realization that they need guidance geared toward their stage of life. Read more on the blog: bit.ly/3RI7ZC6

“My hope is that if every institution throughout the country can have a young adult cancer program, even something small...can provide a large impact for patients,” says Chris Cann, MD in a recent article with Medscape: wb.md/43XTly3

Starting #ECOG spring meeting strong! Kudos to Efrat Dotan MD for sharing her journey—had us all thinking, ‘Wait… how did she do that, and can I borrow some of that brilliance?’ Grateful to call her a mentor and ECOG-ACRIN Cancer Research Group my home. Fox Chase Cancer Center Penn Medicine

For those that cannot attend the annual @asco meeting.... we have created a local meeting w/my co-chair 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 in #heme and #solidtumors. Join us! Muhamed Baljević, MD, FACP Kathy Walsh, MD, MAEd Chris Cann, MD Benjamin Garmezy Christine Lovly, MD, PhD, FASCO Date: Sat 6/21/2025 Location: Conrad Hotel #nashville

Young adult cancer rates are climbing, but care models haven’t caught up. Fox Chase Cancer Center’s Young Adult Cancer Program is addressing this gap with tailored support—from fertility preservation to financial counseling. Learn more on Philly Mag: bit.ly/3Fy3nMo

👉Co-Chair: 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 👉Post ASCO update - CME certified 👉Date: 6/21/2025 👉Registration: MLS Conferences | Summary - MLS Nashville 👉 Alan Tan Christine Lovly, MD, PhD, FASCO Kathy Walsh, MD, MAEd Muhamed Baljević, MD, FACP Chris Cann, MD Ronak H. Mistry, DO #cancer #cancerresearch #PatientCare #Nashville

Couldn’t think of a better person for the job :) Congrats Namrata (Neena) Vijayvergia MD!

An innovative EHR intervention at Fox Chase helped increase fertility preservation referrals for young cancer patients. Learn how this simple change is making a big impact on survivorship care: bit.ly/3FC06f7 #CancerCare #FertilityPreservation Chris Cann, MD

The Medical Educator Consortium MLS #Nashville #cancer post-ASCO update today. So great to see our 🤩 staff (Deb Hawkins, APP) and former Vanderbilt University Medical Center #hemeonc #Fellows 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Kathy Walsh, MD, MAEd Chris Cann, MD Ronak H. Mistry, DO Dr. AC Uhelski. #canceresearch

Dr Chris Cann, MD & team show biweekly TAS-102 #BiTS in #crcsm ⬇️grade ≥3 neutropenia & anemia and maintained similar #PFS (4.2mo) & #OS (9.2mo) vs standard dosing. This schedule may improve tolerability & support combination 💊💉#Bev #GIonc doi.org/10.1093/oncolo…

New research from Fox Chase shows a biweekly dose of TAS-102 cuts toxicity but keeps its cancer-fighting power for patients with metastatic colorectal cancer. Read more from Chris Cann, MD, lead author on the study: bit.ly/3FLB4uc

Check out our Cancer Discovery commentary on the of rise young adult cancer and the critical components of a young adult cancer program to offer optimal support. As always, great to work with my mentor Dr. Cathy Eng. Fox Chase Cancer Center Vanderbilt University Medical Center

A retrospective analysis shows that trifluridine/tipiracil with or without bevacizumab given biweekly was favorable in those with colorectal cancer. Read more from Fox Chase's Chris Cann, MD: bit.ly/3IeuBc2

Young adults with cancer need top notch care—but they also need connection, community, and care that gets them. 💬🎧🧠🧘‍♂️ Join us (and the amazing Chris Cann, MD) as we build a program that heals mind, body & soul—without any crystal balls. Fox Chase Cancer Center